Literature DB >> 2966306

Sarcoplasmic reticulum adenosine triphosphatase deficiency with probable autosomal dominant inheritance.

M J Danon1, G Karpati, J Charuk, P Holland.   

Abstract

We report a family in which four members in two generations (mother, her son, and two daughters) suffered from impaired muscle relaxation aggravated by exercise. Muscle biopsies from two sisters showed moderate degree of histochemical type 2 fiber atrophy and excess of internal nuclei. Microscopic immunocytochemistry, using a monoclonal antibody raised against purified chicken SR-ATPase, revealed severe reduction of the immunoreactive ATPase of SR was markedly decreased on Western blots of muscle proteins. This family appears to have a clinically, electromyographically, and biochemically distinct metabolic myopathy associated with deficiency of SR-ATPase, with a probable autosomal dominant inheritance pattern that is phenotypically similar to recently described recessive cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966306     DOI: 10.1212/wnl.38.5.812

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Ischaemic forearm testing in a patient with Ca(2+)-ATPase deficiency.

Authors:  R A Wevers; P J Poels; E M Joosten; G G Steenbergen; A A Benders; J H Veerkamp
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Ca2+ homeostasis in Brody's disease. A study in skeletal muscle and cultured muscle cells and the effects of dantrolene an verapamil.

Authors:  A A Benders; J H Veerkamp; A Oosterhof; P J Jongen; R J Bindels; L M Smit; H F Busch; R A Wevers
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

3.  A defective SERCA1 protein is responsible for congenital pseudomyotonia in Chianina cattle.

Authors:  Roberta Sacchetto; Stefania Testoni; Arcangelo Gentile; Ernesto Damiani; Marco Rossi; Rocco Liguori; Cord Drögemüller; Francesco Mascarello
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.